At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SD Sandridge Energy Inc.
Trading 04-16 12:18:23 EDT
14.90
+0.04
+0.27%
High15.07Low14.86Vol64.08K
Open15.07D1 Closing14.86Amplitude1.45%
Mkt Cap547.93MTradable Cap537.66MTotal Shares36.77M
T/O956.16KT/O Rate0.18%Tradable Shares36.08M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Create SD's Nine-Month Profit Climbs 9.1%
MT Newswires Live  ·  04-06
Create SD's Nine-Month Profit Climbs 9.1%
Create SD Holdings Lifts Nine-Month Profit and Confirms Higher Dividend as New Subsidiaries Join Group
TIPRANKS  ·  04-06
Create SD Holdings Lifts Nine-Month Profit and Confirms Higher Dividend as New Subsidiaries Join Group
Create SD Holdings 9-Mos Net Y12.21B Vs Net Y11.19B
Dow Jones  ·  04-06
Create SD Holdings 9-Mos Net Y12.21B Vs Net Y11.19B
Lifedrink Completes Acquisition Of SD Next, SD Bottlers Via Unit
MT Newswires Live  ·  04-01
Lifedrink Completes Acquisition Of SD Next, SD Bottlers Via Unit
SD Guthrie's Cost Pressures Likely Offset by Higher Crude Palm Oil Prices -- Market Talk
Dow Jones  ·  03-30
SD Guthrie's Cost Pressures Likely Offset by Higher Crude Palm Oil Prices -- Market Talk
Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026
GlobeNewswire  ·  03-27
Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026
SD Guthrie Releases February Production Report
MT Newswires Live  ·  03-26
SD Guthrie Releases February Production Report
Enercom Announces Initial List of Presenting Companies for the 31St Annual Energy Investment Conference to Be Held August 17-19, 2026, in Denver, Colorado
THOMSON REUTERS  ·  03-19
Enercom Announces Initial List of Presenting Companies for the 31St Annual Energy Investment Conference to Be Held August 17-19, 2026, in Denver, Colorado
SD Guthrie's Outlook May Remain Stable Amid Middle East Conflict -- Market Talk
Dow Jones  ·  03-17
SD Guthrie's Outlook May Remain Stable Amid Middle East Conflict -- Market Talk
SandRidge Energy downgraded to Sell from Buy at Freedom Capital
TIPRANKS  ·  03-10
SandRidge Energy downgraded to Sell from Buy at Freedom Capital
TA Securities Upgrades SD Guthrie to Buy from Sell; Price Target is MYR6.33
MT Newswires Live  ·  03-09
TA Securities Upgrades SD Guthrie to Buy from Sell; Price Target is MYR6.33
SandRidge Energy Q4 Adj. EPS $0.34 Misses $0.37 Estimate, Sales $39.400M Miss $43.700M Estimate
Benzinga  ·  03-05
SandRidge Energy Q4 Adj. EPS $0.34 Misses $0.37 Estimate, Sales $39.400M Miss $43.700M Estimate
SandRidge posts Q4 net income of USD 21.6 million up USD 4.1 million
Reuters  ·  03-05
SandRidge posts Q4 net income of USD 21.6 million up USD 4.1 million
SandRidge Energy Q4 Adjusted EPS USD 0.34
THOMSON REUTERS  ·  03-05
SandRidge Energy Q4 Adjusted EPS USD 0.34
SandRidge Energy, Inc. Announces Financial and Operating Results for the Quarter and Year Ended December 31, 2025, $0.12 per Share Cash Dividend, and 2026 Guidance
THOMSON REUTERS  ·  03-05
SandRidge Energy, Inc. Announces Financial and Operating Results for the Quarter and Year Ended December 31, 2025, $0.12 per Share Cash Dividend, and 2026 Guidance
SandRidge Energy Inc. Updates Financial Calendar
Reuters  ·  03-03
SandRidge Energy Inc. Updates Financial Calendar
Celldex presents new data from Phase 2 ColdU, SD Open Label Extension
TIPRANKS  ·  03-02
Celldex presents new data from Phase 2 ColdU, SD Open Label Extension
Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar Profound Efficacy to First Exposure in Patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026
GlobeNewswire  ·  03-01
Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar Profound Efficacy to First Exposure in Patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026
Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026
GlobeNewswire  ·  02-28
Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026
SD Guthrie's Key Catalysts Appear Priced In -- Market Talk
Dow Jones  ·  02-26
SD Guthrie's Key Catalysts Appear Priced In -- Market Talk

Introduction

Company Name.
Sandridge Energy Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
SandRidge Energy, Inc. engages in the acquisition, development, and production of oil and natural gas primarily in the United States Mid-Continent. As of December 31, 2022, it had an interest in 1,471 gross producing wells. The company was incorporated in 2006 and is headquartered in Oklahoma City, Oklahoma.
Issue price:
--